Randeep Guleria Aiims

The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains

As India witnessed the highest number of Covid cases in over four months, former AIIMS director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise.

Noting a spurt in cases of the H3N2 virus, which has become a cause of concern, Chairman, Institute of Internal Medicine and Respiratory and Sleep Medicine and Director of Medical Education, Dr Randeep Guleria said.

Dr Randeep Guleria, former Director of All India Institute of Medical Sciences (AIIMS) Delhi told NDTV today that the next few days are very crucial for India after a surge in Covid cases in China and other countries.

AIIMS director Randeep Guleria today said the healthcare sector is witnessing a "huge change" due to the fourth industrial revolution and digitisation is revolutionising the way healthcare is provided.

The tenure of Randeep Guleria as the director of the All India Institute of Medical Sciences has been extended by three months.

Meeting of Election Commission of India (ECI) and top officials of health ministry on Thursday to review the COVID-19 situation was attended by AIIMS Director Dr. Randeep Guleria and ICMR Director General Balram Bhargava, informed official sources.

In view of the rising Omicron cases across the country, All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday advised people "not to panic, but to be vigilant" while extending New Year greetings.

All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday said that the Omicron variant of coronavirus is more transmissible and emphasised on vaccination and COVID-19 appropriate behaviour to counter the spread o

The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria has said.

All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said on Sunday that in view of rising COVID-19 cases in the United Kingdom, India should prepare itself for any eventuality.

A third Covid wave of a magnitude comparable to the first two is unlikely to hit India, AIIMS director Dr Randeep Guleria said Tuesday

Booster doses of the COVID-19 vaccine might become necessary sometime next year - depending on how long the first two doses protect against hospitalisation and death - Dr Randeep Guleria, chief of Delhi's AIIMS, told NDTV on Saturday.

Covid has showed the importance of technology and how if used properly can be a game-changer in the country where there is a big issue of resources and manpower crunch as far as the health sector is concerned, AIIMS Director Dr Randeep Guleria said.

Children between 12 to 18 years of age will be vaccinated against COVID-19 very soon, said Dr Randeep Guleria, Director of All Indian Institute of Medical Sciences (AIIMS), Delhi.

The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains

As India witnessed the highest number of Covid cases in over four months, former AIIMS director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise.

Noting a spurt in cases of the H3N2 virus, which has become a cause of concern, Chairman, Institute of Internal Medicine and Respiratory and Sleep Medicine and Director of Medical Education, Dr Randeep Guleria said.

Dr Randeep Guleria, former Director of All India Institute of Medical Sciences (AIIMS) Delhi told NDTV today that the next few days are very crucial for India after a surge in Covid cases in China and other countries.

AIIMS director Randeep Guleria today said the healthcare sector is witnessing a "huge change" due to the fourth industrial revolution and digitisation is revolutionising the way healthcare is provided.

The tenure of Randeep Guleria as the director of the All India Institute of Medical Sciences has been extended by three months.

Meeting of Election Commission of India (ECI) and top officials of health ministry on Thursday to review the COVID-19 situation was attended by AIIMS Director Dr. Randeep Guleria and ICMR Director General Balram Bhargava, informed official sources.

In view of the rising Omicron cases across the country, All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday advised people "not to panic, but to be vigilant" while extending New Year greetings.

All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Wednesday said that the Omicron variant of coronavirus is more transmissible and emphasised on vaccination and COVID-19 appropriate behaviour to counter the spread o

The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria has said.

All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said on Sunday that in view of rising COVID-19 cases in the United Kingdom, India should prepare itself for any eventuality.

A third Covid wave of a magnitude comparable to the first two is unlikely to hit India, AIIMS director Dr Randeep Guleria said Tuesday

Booster doses of the COVID-19 vaccine might become necessary sometime next year - depending on how long the first two doses protect against hospitalisation and death - Dr Randeep Guleria, chief of Delhi's AIIMS, told NDTV on Saturday.

Covid has showed the importance of technology and how if used properly can be a game-changer in the country where there is a big issue of resources and manpower crunch as far as the health sector is concerned, AIIMS Director Dr Randeep Guleria said.

Children between 12 to 18 years of age will be vaccinated against COVID-19 very soon, said Dr Randeep Guleria, Director of All Indian Institute of Medical Sciences (AIIMS), Delhi.